These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1127 related articles for article (PubMed ID: 27911876)
1. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer. Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876 [TBL] [Abstract][Full Text] [Related]
2. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer. Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. Spolverato G; Maqsood H; Kim Y; Margonis G; Luo T; Ejaz A; Pawlik TM J Surg Oncol; 2015 Jun; 111(7):868-74. PubMed ID: 25865111 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy. Miao Y; Yan Q; Li S; Li B; Feng Y Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294 [TBL] [Abstract][Full Text] [Related]
6. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
7. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer. Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024 [TBL] [Abstract][Full Text] [Related]
9. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy. Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194 [TBL] [Abstract][Full Text] [Related]
10. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Shao N; Cai Q Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392 [TBL] [Abstract][Full Text] [Related]
11. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery. Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Qin B; Ma N; Tang Q; Wei T; Yang M; Fu H; Hu Z; Liang Y; Yang Z; Zhong R Mod Rheumatol; 2016; 26(3):372-6. PubMed ID: 26403379 [TBL] [Abstract][Full Text] [Related]
13. Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy. Ha H; Nam AR; Bang JH; Park JE; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY Oncotarget; 2016 Nov; 7(47):76604-76612. PubMed ID: 27780932 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer. Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203 [TBL] [Abstract][Full Text] [Related]
15. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy. Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131 [TBL] [Abstract][Full Text] [Related]
16. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma. Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K Oncology; 2019; 97(1):7-17. PubMed ID: 31048577 [TBL] [Abstract][Full Text] [Related]
17. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience. Dogan M; Eren T; Ozdemir N; Cigirgan CL; Zengin N Saudi J Gastroenterol; 2015; 21(5):320-4. PubMed ID: 26458860 [TBL] [Abstract][Full Text] [Related]
18. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
19. Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer. Lozano Martínez AJ; Moreno Cano R; Escobar Páramo S; Salguero Aguilar R; Gonzalez Billalabeitia E; García Fernández R; De La Fuente Muñoz I; Romero Borque A; Porras Martínez M; Lopez Soler F; Cardenas Cánovas E; Ortega Martín I Clin Transl Oncol; 2017 Dec; 19(12):1531-1536. PubMed ID: 28718070 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]